| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.708 | 12.972 | 29.198 | 33.073 | 44.017 | 38.173 | 38.699 | 30.843 |
| Total Income - EUR | - | - | 10.708 | 12.972 | 29.198 | 33.073 | 44.369 | 38.189 | 38.798 | 30.815 |
| Total Expenses - EUR | - | - | 6.751 | 4.698 | 13.405 | 14.569 | 14.406 | 14.851 | 22.304 | 22.568 |
| Gross Profit/Loss - EUR | - | - | 3.957 | 8.274 | 15.793 | 18.504 | 29.963 | 23.338 | 16.494 | 8.247 |
| Net Profit/Loss - EUR | - | - | 3.636 | 7.966 | 15.502 | 18.043 | 29.551 | 22.964 | 16.114 | 7.444 |
| Employees | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Velaflor Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.617 | 1.297 | 994 | 703 | 831 | 293 | 20.530 | 14.291 |
| Current Assets | - | - | 2.123 | 7.179 | 16.519 | 32.475 | 26.423 | 23.495 | 15.264 | 10.898 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 226 | 227 | 0 | 0 |
| Receivables | - | - | 20 | 6.050 | 13.266 | 13.278 | 15.371 | 19.680 | 14.990 | 10.385 |
| Cash | - | - | 2.103 | 1.129 | 3.253 | 19.196 | 10.825 | 3.588 | 274 | 513 |
| Shareholders Funds | - | - | 3.680 | 8.017 | 17.041 | 31.124 | 25.234 | 23.012 | 16.170 | 12.033 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 60 | 458 | 472 | 2.054 | 2.019 | 775 | 19.624 | 13.170 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Velaflor Med Srl